Lista de obras -

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

artículo científico publicado en 2018

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for and CD39

article

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy.

artículo científico publicado en 2011

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy.

artículo científico publicado en 2011

Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor

scholarly article by Timothy R. D. J. Radstake et al published 2005 in Arthritis and Rheumatism

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

artículo científico publicado en 2010

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

artículo científico publicado en 2010

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

artículo científico publicado en 2014

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

artículo científico publicado en 2017

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

artículo científico publicado en 2011

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

artículo científico publicado en 2016

Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

artículo científico publicado en 2016

Erratum: Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

scholarly article published in Nature Genetics

Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome

artículo científico publicado en 2010

Genetics of rheumatoid arthritis contributes to biology and drug discovery

artículo científico publicado en 2013

Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis

artículo científico publicado en 2012

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

artículo científico publicado en 2013

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

artículo científico publicado en 2010

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

artículo científico publicado en 2010

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

artículo científico publicado en 2011

Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up

artículo científico publicado en 2012

Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

artículo científico publicado en 2011

Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis

artículo científico publicado en 2010

MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis.

artículo científico publicado en 2003

MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda

artículo científico publicado en 2003

MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis

scientific article published on 01 October 2006

Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci

scientific journal article

Minimal disease activity for rheumatoid arthritis: a preliminary definition

artículo científico publicado en 2005

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis

artículo científico publicado en 2015

One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology

artículo científico publicado en 2020

Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers

artículo científico publicado en 2020

Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: Economic Evaluation of a Randomized Controlled Trial

artículo científico publicado en 2018

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

artículo científico publicado en 2014

The functional polymorphism 844 A>G in FcαRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility

artículo científico publicado en 2010

Lista de obras de

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for and CD39

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy.

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy.

Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor

Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

Erratum: Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome

Genetics of rheumatoid arthritis contributes to biology and drug discovery

Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up

Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

Identification of the oxidative stress-related gene MSRA as a rheumatoid arthritis susceptibility locus by genome-wide pathway analysis

MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis.

MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda

MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis

Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci

Minimal disease activity for rheumatoid arthritis: a preliminary definition

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis

One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology

Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers

Tailored, Therapist-Guided Internet-Based Cognitive Behavioral Therapy Compared to Care as Usual for Patients With Rheumatoid Arthritis: Economic Evaluation of a Randomized Controlled Trial

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

The functional polymorphism 844 A>G in FcαRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility